NCT06724952View on ClinicalTrials.gov

Effect of Silymarin in Rheumatoid Arthritis Patients Treated With Methotrexate

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

December 10, 2024

Primary Completion Date

March 10, 2025

Study Completion Date

April 10, 2025

Conditions
Rheumatoid Arthritis (RA)
Interventions
DRUG

MTX S.C or IM and Silymarin 140 mg tab

IM or S.C Methotrexate plus Silymarin tablets 140 mg once daily for 3 months.

DRUG

MTX S.C or IM

IM or SC Methotrexate plus placebo tablet once daily for 3 months.

Trial Locations (1)

35511

Outpatient Clinic of Internal Medicine, Rheumatology and Immunology Department, Mansoura University Hospital, Mansoura, 35511, Al Mansurah

All Listed Sponsors
lead

Tanta University

OTHER